Cargando…
Crizanlizumab: A CRITICAL Drug During a CRITICAL Time?
[Figure: see text]
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733743/ https://www.ncbi.nlm.nih.gov/pubmed/35024499 http://dx.doi.org/10.1016/j.jacbts.2021.10.013 |
| _version_ | 1784627867118731264 |
|---|---|
| author | Gue, Ying X. Pula, Giordano Lip, Gregory Y.H. |
| author_facet | Gue, Ying X. Pula, Giordano Lip, Gregory Y.H. |
| author_sort | Gue, Ying X. |
| collection | PubMed |
| description | [Figure: see text] |
| format | Online Article Text |
| id | pubmed-8733743 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87337432022-01-11 Crizanlizumab: A CRITICAL Drug During a CRITICAL Time? Gue, Ying X. Pula, Giordano Lip, Gregory Y.H. JACC Basic Transl Sci Clinical Research [Figure: see text] Elsevier 2021-12-27 /pmc/articles/PMC8733743/ /pubmed/35024499 http://dx.doi.org/10.1016/j.jacbts.2021.10.013 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Clinical Research Gue, Ying X. Pula, Giordano Lip, Gregory Y.H. Crizanlizumab: A CRITICAL Drug During a CRITICAL Time? |
| title | Crizanlizumab: A CRITICAL Drug During a CRITICAL Time? |
| title_full | Crizanlizumab: A CRITICAL Drug During a CRITICAL Time? |
| title_fullStr | Crizanlizumab: A CRITICAL Drug During a CRITICAL Time? |
| title_full_unstemmed | Crizanlizumab: A CRITICAL Drug During a CRITICAL Time? |
| title_short | Crizanlizumab: A CRITICAL Drug During a CRITICAL Time? |
| title_sort | crizanlizumab: a critical drug during a critical time? |
| topic | Clinical Research |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733743/ https://www.ncbi.nlm.nih.gov/pubmed/35024499 http://dx.doi.org/10.1016/j.jacbts.2021.10.013 |
| work_keys_str_mv | AT gueyingx crizanlizumabacriticaldrugduringacriticaltime AT pulagiordano crizanlizumabacriticaldrugduringacriticaltime AT lipgregoryyh crizanlizumabacriticaldrugduringacriticaltime |